Source:http://linkedlifedata.com/resource/pubmed/id/19400209
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:dateCreated |
2009-4-29
|
pubmed:grant | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:issn |
0065-2598
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
611
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
319-20
|
pubmed:meshHeading | |
pubmed:year |
2009
|
pubmed:articleTitle |
A combination of ligand SAR and receptor site-directed mutagenesis reveals requirements for antagonist activity at the melanocortin-3 receptor.
|
pubmed:affiliation |
Department of Medicinal Chemistry, University of Florida, Gainesville, FL 32610, USA.
|
pubmed:publicationType |
Journal Article,
Research Support, N.I.H., Extramural
|